Protection from acute infection requires an immediate response by the host innate immune system. Two recent Cell papers, including one in this issue, provide new insight into the role of the complement system in response to blood-borne pathogens.
Pattern Recognition in Innate Immunity
Our immune system is continuously faced with the challenge of protecting us from infection against an army of pathogens. When infection does occur, the effective elimination of most pathogens requires the activation of both the innate and the adaptive tiers of the immune system. The innate immune response in large part relies on phagocytic and granulocytic cells expressing germline-encoded invariant receptors that recognize pathogen-associated molecular patterns (Medzhitov and Janeway, 2002) . These pattern-recognition receptors mediate killing of the recognized microbe by triggering phagocytosis. Apart from the prototypic Toll-like receptors, there has been an increasing appreciation of the importance of other kinds of pattern-recognition receptors (reviewed in Brown [2006] ). Soluble pattern-recognition receptors, such as mannan binding lectin, can contribute to pathogen clearance via activation of the complement system. The complement system is a class of over 20 soluble and cell-surface proteins that react to the exposure to foreign antigens by initiating a regulated cascade of reactions. There are three major pathways of complement activation (Figure 1 ). Binding of mannan binding lectin to microbial surface activates the complement lectin pathway that converges with the classical pathway at the level of complement C4 (a component of one of the heteromultimeric enzyme complexes). Even though the complement system evolutionarily predates the adaptive immune response, it has been adapted to mediate crosstalk between the adaptive and innate responses. Of the three pathways, the classical pathway of complement activation-which is initiated by immunoglobulins and then proceeds via C1q (a subunit of the C1 enzyme complex)-is thought to participate most directly in the adaptive response. The alternative pathway of complement is considered the original complement pathway and is even found in ascidians, such as sea squirts and sea urchins (reviewed in Fujita [2002] ). Although the three pathways are activated independently, it is becoming increasingly apparent that they interact at various levels. Downstream complement activation has the potential for direct destruction of pathogens via the C5-C9 membrane attack complex (MAC). The C3a and C5a fragments function as chemokines, recruiting phagocytic and granulocytic cells to sites of inflammation. SIGN-R1 can activate the classical pathway of complement (Kang et al., 2006) . CRIg is a new clearance receptor recognizing the C3b and iC3b fragments of complement C3 (Helmy et al., 2006 ; MBL, mannan binding lectin; MASP, MBL-associated serine protease).
In this minireview, we focus on the role of complement in opsonization, the process by which products of the complement pathway coat antigens. For example, fragments of complement C3 and C4 bind covalently to a pathogen's surface and in effect tag the pathogen as foreign. Complement receptors recognizing these tags modulate the subsequent immune response or directly target the pathogen for clearance. In a recent issue of Cell, Helmy et al. (2006) described a new complement receptor of the Ig superfamily, CRIg, which mediates the complement-dependent clearance of pathogens by Kupffer cells in the liver. In this issue of Cell, Kang et al. (2006) introduce a new mechanism of classical pathway activation by pneumococcal capsular polysaccharides. They make the surprising observation that the C-type lectin patternrecognition receptor SIGN-1 binds complement C1q, leading to activation of the classical pathway. Here, we describe the new insights generated by their findings and integrate them into a more general pattern of complement-mediated recognition and clearance of pathogens. We will also discuss the implications of these studies on the regulation of local infection and systemic autoimmune disease.
New Pattern-Recognition Receptors in Complement Activation and Complement-Mediated Clearance CRIg: Immune Clearance Revisited Four receptors for fragments of complement C3 had been described to date (reviewed by Holers et al. [1992] ). To this panel Helmy et al. (2006) now add a fifth member, CRIg. They demonstrate that CRIg has affinity for C3b and iC3b, but not for other complement components. CRIg is expressed on tissue-resident macrophages, including Kupffer cells in the liver. In the absence of CRIg, C3-opsonized particles fail to bind to Kupffer cells, indicating that CRIg is the dominant C3 receptor on Kupffer cells, in spite of the fact that they may also express the receptor CR3 (also called Mac-1, CD11b/CD18). Importantly, Helmy et al. (2006) identify CRIg as a phagocytic receptor for the C3-dependent clearance of blood-borne pathogens. The absence of CRIg strongly enhances susceptibility to these pathogens.
Rapid capture of bacteria in the liver during the first minutes to hours after introduction to the blood is crucial to prevent systemic bacteremia. Clearance of bacteria through the liver involves both adaptive (i.e., FcR-mediated phagocytosis) and innate mechanisms. Innate immunity-mediated mechanisms include both scavenger and complement receptors. For instance, CR3 on Kupffer cells is implicated in preventing bacteremia. It now appears that a second receptor, CRIg, mediates clearance of C3-opsonized pathogens.
In addition to clearance of pathogens, CRIg + Kupffer cells could play an important role in removing complement-tagged self-antigens, such as apoptotic cells and cell remnants. In the prototypical autoimmune disease systemic lupus erythematosous, the deposition of immune complexes of self-antigen and self-reactive antibody in the kidney leads to glomerulonephritis. Defects in complement are thought to exacerbate Lupus via a reduction in normal immune complex clearance, resulting in an increased deposition of pathogenic complexes in the kidneys, enhancing inflammation and ultimately resulting in kidney failure. Given the importance of CRIg in clearance, it could play an important role in limiting renal injury through rapid clearance of potentially pathogenic immune complexes. It will be therefore be very informative to learn whether CRIg-deficient mice are predisposed to the development of autoimmune disease.
SIGN-R1: Lectin Activation of the Classical
Complement Pathway SIGN-R1 is a cell surface C-type lectin receptor with homology to DC-SIGN. Earlier work on this receptor has shown that it is expressed on marginal-zone macrophages (Geijtenbeek et al., 2002) and is important in resistance to pneumococcal infection (Lanoue et al., 2004) . Other studies found that immunity to Streptococcus pneumoniae also requires the classical pathway of complement (Brown et al., 2002) . Kang et al. (2006) now elegantly integrate these findings into a single concept by showing that SIGN-R1 activates the classical pathway of complement on the surface of marginal-zone macrophages. SIGN-R1 binds C1q as well as S. pneumoniae polysaccharide, leading to the C4-dependent deposition of C3 on the captured polysaccharide and on S. pneumoniae. Remarkably, C3 deposition does not require the involvement of antibodies, making it a classical but immunoglobulinindependent pathway of complement activation. This is the first description of a cell surface lectin directly initiating the classical pathway of complement activation. Given that the absence of C3 results in a greater susceptibility to S. pneumoniae than deficiency in SIGN-R1, it is likely that natural IgM-activated classical pathway and conceivably other lectins also contribute to S. pneumoniae resistance.
Macrophages express a range of lectins, for many of which the ligands remain unknown. The emerging role of SIGN-R1 as a complement activator, as well as the identification of CRIg as a new clearance receptor on Kupffer cells could provide insight into additional mechanisms of the innate response against bloodborne pathogens.
Convergence on Complement Effector Mechanisms in the Spleen
The spleen is the main and final line of defense against blood-borne pathogens. Splenic structure is uniquely suited to mediate the extremely rapid response that is required when sepsis occurs (reviewed in Mebius and Kraal [2005] ). Most of the blood passes through the marginal zone, bringing the contents into intimate contact Cell 125, April 7, 2006 ©2006 Elsevier Inc. 31 with marginal-zone macrophages, marginal-zone B cells, and a subset of dendritic cells (Figure 2 ). Marginal-zone macrophages are defined by their expression of SIGN-R1 and the scavenger receptor MARCO. SIGN-R1 mediates complement activation upon exposure to certain microbial polysaccharides (Kang et al., 2006) . The marginal zone is also rich in a subset of B-lymphocytes termed marginal-zone B cells. They are characterized by distinct cell-surface protein expression patterns that include high expression of complement receptors. Another subset of macrophages, marginal-zone metallophilic macrophages, line the inner edge of the marginal sinus and are defined by expression of Sialoadhesin (also called Siglec-1; sialic acid binding Ig-like lectin). Deficiencies in Siglec-1, as well as in the scavenger receptors MARCO and SR-A, were shown to disrupt marginal-zone composition and function (Oetke et al., 2006; Chen et al., 2006) . Both MARCO-and SIGN-R1-deficient mice are known to be more susceptible to S. pneumoniae when compared to wild-type mice (Arredouani et al., 2004 , Lanoue et al., 2004 but still notably less sensitive than C3-deficient mice. It appears that overlapping pathogen-recognition pathways converge at the level of C3. Therefore, complement may be the dominant clearance mechanism within the spleen. This may become increasingly relevant when infection is more complicated, such as infection by more than one pathogen (Lysenko et al., 2005) . Not all pathogens equally activate all innate defense mechanisms, and not all defense mechanisms are equally effective against all pathogens. Channeling responses from an array of broadly specific pattern-recognition receptors into a restricted number of effector mechanisms may be the best way to ensure reliable immunity against an unpredictable and constantly changing environment.
The blood-borne phase of infections is usually preceded by microbial colonization of peripheral tissues or mucosal surfaces. Innate immune mechanisms also battle the pathogen on-site. Both natural antibodies and pattern-recognition receptors such as mannan binding lectin activate complement directly upon exposure to microbial antigens, opsonizing the pathogen for phagocytosis and recruiting granulocytes and phagocytes in the process. Bacterial antigens are transported to the draining lymph node, where adaptive immune responses are initiated. Even though lymph nodes lack the marginal zone that is optimally suited to handle pathogens, most infections are contained before they become systemic. In the absence of marginal-zone B cells and marginal-zone macrophages in the lymph node, antigen must be transported into follicles via other mechanisms for the priming of the adaptive immune response to occur ( Figure  2 ). Subcapsular sinus macrophages and dendritic cells are implicated in this process (Martinez-Pomares et al., 1996 , Berney et al., 1999 . Local complement production in the lymph node is important for antiviral immunity (Verschoor et al., 2003) , suggesting that mechanisms of pathogen recognition and clearance may be common between peripheral lymph nodes and spleen. However, further details regarding specific pattern-recognition receptors and the cell types involved will be necessary to complete our understanding of pathogen clearance in the lymph node.
Dual Recognition of Foreign and Self-Antigens by Pattern-Recognition Receptors Both macrophages and dendritic cells express the mannose receptor, ligands for which are present on a range of microbes, as well as on marginal-zone metallophilic macrophages and a subset of dendritic cells and include Siglec-1. Other members of the Siglec family have diverse expression patterns and harbor the potential for recognizing both self-and foreign antigens. Pattern recognition might therefore have evolved out of a need for self-recognition upon increasing cellular diversification, being adapted for defense purposes later (Gordon, Apart from the lack of marginal zones, lymph nodes strongly resemble the splenic white pulp. In the absence of marginal-zone B cells and marginal-zone macrophages, antigen-transport processes are likely to differ substantially between the lymph node and the spleen.
2002). Introduction of pneumococcal polysaccharide or model carbohydrate antigens (referred to as T-independent type 2 antigens) into the blood leads to rapid localization on marginal-zone macrophages. Marginal-zone B cells take over the antigen in a complement-dependent manner (Kang et al., 2006) and transport it into the follicles where it is deposited on follicular dendritic cells. The absence of marginal-zone B cells or disruption of marginal-zone macrophages interferes with this process (Karlsson et al., 2003) , as follicular localization of the antigen is abolished, and the subsequent adaptive immune response is strongly impaired (Guinamard et al., 2000) . Thus, the various subsets of macrophages and marginal-zone B cells are highly interdependent. The new results by Kang et al. (2006) provide further insight into this intricate network of marginal-zone macrophages and marginal-zone B cells and the recognition of T-independent antigens. It will be important to learn whether binding of bacteria by SIGN-R1 enhances interaction with C1q and subsequent complement activation. Moreover, it is tempting to speculate that signaling via SIGN-R1 and complement receptors is responsible for release of the antigen-laden marginal-zone B cells into the follicles.
Conclusions
The complement system has been studied intensely since its identification over a century ago. Helmy et al. (2006) and Kang et al. (2006) demonstrate additional levels of regulation in complement-mediated pathogen recognition and clearance. Their findings have important implications for complement activation in peripheral immune responses and immune clearance. No doubt these new and interesting results will spark continued interest in this important area of research.
